Transmed Academy

In this online self-paced course, you will be introduced to regulatory aspects of vaccine development, including:​

• How to navigate the regulatory maze
• Chemistry, Manufacture and Control (CMC)
• Regulatory landscape for preclinical testing
• Clinical Vaccine Development
• Cancer vaccines and ATMPs
• Scientific basis of Cancer vaccines
• COVID-19 vaccines development

Target audience: professionals working on vaccine development who need an introduction to the (EU) regulatory requirements associated with the field

Investment time: This course has an average study load of 8 – 10 hours

Format:  online, self paced

In this online self-paced course, you will be introduced to the concept of translational science and medicine, including:​

• Introduction to translational medicine​
• Target validation​
• Predictive models​
• Biomarkers​
• Clinical Trial and Implementation​
• Regulatory environment and IP

Target audience: anyone interested in learning more about translational medicine

Investment time: This course has an average study load of 8 – 10 hours

Format:  online, self paced

Cost: free of charge

This online self-paced course  consists of 4 Units representing the key challenges of the ATMPs development cycle – Scientific, Manufacturing, Reimbursement and Regulatory. Participants will have a chance to listen to talks by 12 top scientists, industry experts and regulators in the field, get acquainted with the relevant literature, and complete assignments such as developing a potency assay strategy for a new ATMP​, building a submission dossier for regulatory review for a new cell therapy​, and performing a Health Technology Assessment on an ATMP using the HTA Core Model. 

Target audience: anyone interested in the ATMPs development topic

Investment time:  The course has ca. 10 hours of interactive lectures and nearly 30 hours of independent assignments and bonus materials

Format:  online, self paced

Cost: free of charge

This short series provides a general overview of the PERMIT project and the recommendations it developed. It begins by introducing the personalised medicine research pipeline and the methods used for development of the recommendations.

Each of the stages of the pipeline is briefly presented, with the main challenges of the stage and how the recommendations can help to address them.

Target audience: Senior academics, healthcare providers and industry

Investment time: average study load is 5 hours

Format: self-paced elearning

Cost: free of charge

The course will address research issues related to Translational Research and Rare Diseases 

Target audience: While primarily designed for medical students and PhD/post-doc students in biomedical sciences, it will also be of interest to Patients Advocacy Organisations’ representatives, Healthcare professionals or paramedics who want to further their knowledge of rare diseases diagnosis.

Investment time:  5 weeks (3 hours/ week)

Format:  online, self paced

Cost: free of charge

The next TMex course will take place in Berlin from 13-17 November 2023.The course covers a variety of activities, including a drug discovery game, elevator pitches, group work and lectures. Experts in the field from academia and industry will be addressing essential elements of the translational pipeline such as target validation, target product profiles, quality and reproducibility, clinical trials, regulatory support, patients driven research and personalized medicine. Several innovation sessions will take place, covering the business canvas model, critical success factor in the translational pathway and how communicate your research to society.

Course fee and registration

The full fee is of 650 Euro. A special discounted fee of 500€ applies for EATRIS members.
Registration is open until 1 October 2023. There are only 30 seats, so we recommend applying early (first come, first served). The registration will close when all seats have been filled. You will need to submit a biosketch and a motivation letter which will be reviewed by a selection committee.

EATRIS-Plus Summer School in Personalised Medicine has been developed within the framework of EATRIS-Plus Project, that is a 4-year flagship initiative in personalised medicine, coordinated by EATRIS ERIC.

The Summer School is organised by INFARMED – EATRIS Portugal node in collaboration with University of Ljubljana – EATRIS Slovenia node. 

The curriculum is designed to address a wide array of topics from structural pillars of personalised medicine, applications and challenges, biomarkers – from bench to the clinic and omics technologies.

The overarching topic of the summer school is personalised medicine with a focus on challenges and opportunities along the biomarker development pipeline. The highlight will be on the best practices on biomarkers translation process into clinical practice. The four days comprise of lectures, interactive workshops and a roundtable.

The workshop will take place 17-20 APRIL 2023 in Lisbon.

EATRIS-Plus project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871096.

ADVANCE 5-day Workshop will take place face-to-face 5-9 June 2022 in Ljubljana, Slovenia. The workshop built on the knowledge of the online course on ATMPs development launched in December 2020. The agenda follows the 4 key challenges and bottlenecks of the ATMPs development cycle: Scientific, Manufacturing, Regulatory, and Reimbursement/ Commercialisation.  In addition clinical aspects will also be discussed.

Participants will hear keynote lectures by experts, complete hands-on group assignments, and get a chance to present their research projects to peers and a panel of experts in a virtual poster session.

Course fee and registration

• Attendance is free of charge; however, participants are responsible for their own travel and accommodation costs. Lunch and coffee breaks are also provided free of charge at the event venue by the organizer
• Register here
• 30 seats available
• Prerequisite to attending the Workshop is completing the ‘Cell & Gene Therapies – ATMP development’ online course by 15 May 2023. More info about the free, self-paced, 7 hour course can be found on EATRIS Transmed Academy website.

EATRIS-Plus workshop on Academia-Industry Collaboration has been developed within the framework of EATRIS-Plus H2020 Project, a 4-year flagship initiative in personalised medicine, coordinated by EATRIS ERIC. The workshop is organised by University of Ljubljana, Faculty of Pharmacy (Slovenia), Biocat, Barcelona (Spain) and EATRIS.

Target audience: Biotech SME-based professionals, Postdoctoral biomedical researchers, Young PIs, Professionals from TTO / Incubators / Industry Liaison, Other professionals from pharmaceutical industry.

Course fee and registration

The two-day workshop took place on 29-30 September 2022 in beautiful Ljubljana, Slovenia.

Tuition fully covered by EATRIS-Plus project for 40 participants

EATRIS-Plus project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871096.

Training scientists in vaccine research and development is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up training modules at leading European centres (in collaboration with WP18 partners) that can be combined to create customised international courses on vaccine research and development (R&D). Participants can select topics as needed in their field of vaccine development, and the timelines of the various modules will be harmonised in a way that allows a logical continuation from one topic to the other.

Organised by EATRIS, this two-day training workshop on vaccine development will introduce participants to planning a regulatory strategy for vaccines with an emphasis on the early phases of development.

Day 1 will focus on prophylactic vaccines, including lectures and case studies on how to navigate the regulatory maze and how to plan a regulatory strategy, preclinical and Phase I-II of vaccine development, how to prepare a dossier for Medicine Agencies, CMC development.

Day 2 will focus on cancer vaccines, with an introduction to the scientific part to understand the regulatory part better.

The course is designed for professionals working on vaccine development who are in need of an introduction to the regulatory issues associated with the field.

Applications are open until 31 December 2022.

This webinar is a part of a comprehensive online course on the Advanced Therapy Medicinal Products (ATMPs) development pipeline designed by the ADVANCE Project – www.eatris.eu/advance

The scope of the webinar is Scientific Advice for ATMPs and Q&A covering the three areas of advice: quality, non-clinical and clinical development.

Target audience: (senior) scientist involved in Advanced Therapy Medicinal Products (ATMPs) development

Investment time: 1 hour per webinar​

On demand

In this webinar, you will learn from ex-regulators how regulators think, and learn how to navigate the regulatory landscape. You will have a clearer understanding of how to turn your research into efficient product development, always with the end in mind. Take the opportunity to learn more about:

• How to take your product to the market, you have to decide what kind of product it is, i.e. which regulatory framework to follow. Why this is important and how to choose.
• How do you prove that your medical device complies with the regulations? The concepts of safety and efficacy as well as risk/benefit assessment, and a brief note on quality management systems – why and when? What is a clinical evaluation, and how can it be used to add value in my product development?
• Learn more about how to take advantage of establishing a TPP, target Product Profile, early in the development. How do you plan your development program to obtain an effective and safe product, with suitable quality, that can be approved by the regulatory authorities and meet the market needs?

Target audience: researchers/professionals who wish to know more about the regulatory aspects of the development of products in the life sciences.

Investment time: 1 hour per webinar​

On demand

Horizon Europe will be a key lever to bring momentum on innovation, putting the emphasis on the importance of translating research and innovation results into benefits for society. This webinar programme is designed exclusively for EATRIS members to help them optimise the fundability of their research, particularly under the Horizon Europe framework programme.

EATRIS offers a range of services to help researchers strengthen the translational potential of their research proposals. In this webinar, the EATRIS Coordination and Support team will take you through the range of support offered by EATRIS to members, including

• how to involve EATRIS as a partner in your research proposal.  
• how to design and implement a robust innovation management strategy for your proposal.  
• how to address the data management needs of your research project and on how to prepare a robust data management plan.  

Target audience: EATRIS researchers and EU Grants officers who are interested in learning more about how to optimise the fundability of their research, particularly under the Horizon Europe framework programme.

Investment time: 1 hour per webinar​

On demand

EATRIS has developed a series of webinars looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). These webinars have been developed in close collaboration with other Research Infrastructures (EU-OPENSCREEN, INFRAFRONTIER, BBMRI, ECRIN) and initiatives such as Translation Together.

Target audience: (senior) scientist interested in learning more about quality & reproducibility in drug development

Investment time: 1 hour per webinar​

On demand

The EATRIS “EATx” online webinar series showcases EATRIS to the world; from institutes to experts; partners to projects. People can tune in to get a better overview of the possibilities of partnering with EATRIS and the successes that follow.

Target audience: anyone interested in learning more about partnering with EATRIS

Investment time: 25 min – 1 hour per webinar​

On demand

EATRIS-Plus project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871096.

Target audience: academic researchers and research funders, policymakers and industry scientists interested in drug repurposing

Investment time: 2 hours per webinar​

On demand

The ENRIITC project aims to build a permanent pan-European network of Industrial Liaison and Contact Officers (ILOs and ICOs) and enable industry to become a full partner of research infrastructures whether it is as a user, a supplier, or a co-creator.​

ENRIITC your Knowledge is a series of online training and organisational webinars targeted to experts involved in setting up collaborations between Research Infrastructures and Industry, such as ILO and ICO.​

Target audience: Industrial Liaison and Contact Officers (ILOs and ICOs)

Investment time: 30 min – 1 hour​ per webinar

On demand

EATRIS and NEURATRIS have launched a series of webinars on cutting-edge methodological and technical developments in neuroimaging. The series covers the usage of CEST-MRI, optical imaging, PET and Ultrahigh Field MRI in neurodegenerative diseases and their potential application in translational medicine.

Target audience: (senior) scientist involved in bioimaging in neurodegenerative diseases

Investment time: 1 hour webinar​

On demand​

​

ADVANCE is a 30-month EU training project, supported by Erasmus Plus with the objective to develop a 3-stage blended learning programme to support early-career biomedical scientists in developing currently missing scientific knowledge, transversal skills and competences to meet the key challenge areas existing in the ATMP development cycle.

Each cycle of the programme will have 7 webinars, completely free of charge and open for all. Three of the webinars are focusing on career development (CV and motivation letter writing, preparing for a job interview, and maintaining a good work-life balance). Four webinars will be handling the key challenges of ATMP development (Scientific, Manufacturing, Reimbursement and Regulatory).

Target audience: the “next generation of ATMP developers” – i.e. early-career biomedical scientists working in the field of advanced therapeutics

Investment time: 1 hour per webinar​

On demand

EATRIS-Plus Staff Exchange Programme is an integral part of the long-term sustainability of EATRIS and its individual nodes. It is designed to stimulate interactions between the nodes and all EATRIS members institutions.  The aim of the exchanges is to foster a shared culture of research and innovation, supporting individual learning, best practice and knowledge exchange in the areas of infrastructure operations, technical development (laboratory work), and stakeholder management.

Launched in 2022, please see here for more information.

EATRIS-Plus project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871096.

As a part of EATRIS capacity building, we are offering a Communications workshop to the EATRIS National Coordinators as a part of the EATRIS-Plus Project.

The workshop will focus on community building within the national node. Registration details will be emailed to National Coordinators ahead of the session.

Target audience: EATRIS National Coordinators

Date: 4 November 2021 at 13:00-15:00 CET​

Format: online internal Event 

EATRIS-Plus project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871096.

i2TRON (Integrating immune strategies for Translational Research in Oncology and Neurology), is a multidisciplinary doctoral training program within the biomedical research community in Luxembourg.

To address the current need for an interactive and interdisciplinary research culture and to implement integrative translational research concepts, it recruits PhD students with either a life sciences or medical background. Its overarching goal is to develop the ability of doctoral candidates to successfully translate fundamental research findings into innovative pre-clinical and clinical applications, thereby shaping the next generation of translational scientists and developing advanced precision medicine and care. The focus of the research program is chronic inflammation, immune-oncology and neuroimmunology. The translational objectives are strongly reflected in the i2TRON training program, which is aligned with EATRIS framework of a translation scientist. The i2TRON mandatory and optional training (publicly available on the webpage) is sourced nationally and internationally from topic-specific and translational training opportunities and color-coded to easily show who can access the training.

i2TRON is funded over a period of 6.5 years by the Luxembourg National Research Fund (FNR) through the competitive PRIDE program.

The Industrial Pharmacy postgraduate program at the University of Ljubljana is designed to equip students for careers in the pharmaceutical industry and scientific research on an advanced level. Graduates of Industrial Pharmacy may find employment in drug discovery, development, production, quality control, quality assurance and management, regulatory affairs and equipment management in the pharmaceutical sector.

The program aims to:

• give an overview of basic concepts in pharmaceutics and industrial pharmacy;
• familiarize students with a complete drug development process that leads to safe, effective and high-quality product:
• provide advanced knowledge in pharmaceutical science such as Quality by Design;
• develop a wide range of essential and transferable skills such as analytical problem solving, teamwork, organization, and information communication.
• equip students to pursue careers in the pharmaceutical industry or in other roles in the life science sector.
• give students the advanced knowledge, skills and experience to compete for sought after roles in the pharmaceutical sector.

The extent of studies is 120 ECTS for the Master’s Degree in Industrial Pharmacy and lasts typically 2 academic years. The academic year is split into two semesters, in which students are required to complete a combination of compulsory and elective modules. Students may select elective modules from other study programs offered by the University of Ljubljana. The modules can be selected on the basis of the scientific research project, which students undertake in the last semester.

The Master in Translational Biomedical Research is an official master’s degree, led by Vall d’Hebron Research Institute (VHIR) and Autonomous University of Barcelona  (UAB), that aims to generate excellent biomedical researchers with the necessary combination of scientific and medical knowledge, and skills to contribute successfully to the future of translational medical research.

Credits:      60 ECTS

Mode:         On-site (VHIR, Barcelona, Spain)

Start:           September of each year

Seats:          50

Language:  Spanish-English

Further information and applications on the Master’s website.

X-omics online workshop series

In June 2020, X-omics organized the first online workshop series. Different aspects of challenges and solutions related to multi-omics data integration were addressed in four workshops.

You can find the materials and recordings for these 4 workshops here on X-omics website. Make sure to check back regularly for upcoming events, such as the X-omics Festival.

Partners of Translation Together, including EATRIS, have published their training courses and other resources on an easy-to-navigate page on the Translation Together website. The training services available can be filtered for free courses or courses targeted toward a specific audience.

The EQIPD E-learning is a course on the principles of rigour and robustness in preclinical research, focusing on in vivo animal experiments. The course is comprised of 10 modules, covering essential learning objectives on e.g. study design and data analysis. Each module consist of several training materials, which have been reviewed and selected by EQIPD experts in the field

The course will address research issues related to diagnosis in the rare diseases context.

Topics covered

• The diagnostic process and the types of genetic tests available for rare diseases
• The differences in rare genetic diseases patient pathways
• Technological advances for diagnostic research
• The role of collaborative studies and data sharing in rare diseases diagnosis
• The impact of having a diagnosis or lacking a diagnosis on patients’ lives
• The role and place of physiopathology approaches as well as social sciences research in the context of rare diseases diagnosis.

Target audience: While primarily designed for medical students and PhD/post-doc students in biomedical sciences, it will also be of interest to Patients Advocacy Organisations’ representatives, Healthcare professionals or paramedics who want to further their knowledge of rare diseases diagnosis.

Investment time:  5 weeks (3 hours/ week)

Format:  online, self paced

Cost: free of charge

PhD Career Stories (PhDCS) is the podcast for people who are interested in career possibilities after a PhD. It provides inspiring interviews with PhDs from multiple disciplines as well as career experts who share their personal experiences and important tips & tricks for career development. To date, PhDCS has published 117+ episodes with >100 speakers from over 20 countries.

PhDCS is available on all major podcast platforms (Apple, Spotify, Google Podcasts, Stitcher, CastBox, Podbean and others), YouTube as well as Social Media (LinkedIn, Facebook, Instagram, Twitter).

The Patient Engagement Resource Centre (or ‘PERC’) is an easy-to-navigate platform that features publicly available guidance, training and practical tools to help researchers get started with patient engagement, particularly in the early stages of biomedical research.  

This initiative aims to make patient engagement in academic research the ‘new normal’, promote responsible research practices, and enable researchers to engage with patients in a meaningful way.  

The Assay Guidance Manual (AGM) is an eBook of best practices for the design, development, and implementation of robust assays for early drug discovery. Originally written as a guide for therapeutic project teams within a major pharmaceutical company, this manual has been adapted to provide guidelines for scientists in academic, non-profit, government and industrial research laboratories to develop assay formats compatible with High Throughput Screening (HTS) and Structure Activity Relationship (SAR) measurements of new and known molecular entities.

The Biomarker Commercialization toolset focuses on in-vitro diagnostics (IVD)-applicable biomarkers and includes BIC Best Practices Handbook, BIC Commercialization Guide including a self-evaluation tool, BIC Screening and Selection Guide for TTO’s, and BIC Regulatory Guide.

The Innovation Management Toolbox is a reference library of resources in rare disease translational medicine. It is free to use and has been designed to provide investigators with self-help resources specific to their needs. Each resource is curated to improve searchability and the database is actively maintained.
The toolbox also includes a Q&A section, use cases and integrates the Catalogue of Services from ERICA project.

The landscape of translational medicine can be seen as a ‘bumpy road’, full of obstacles. Get on the road and discover the landscape of translational medicine along the way!

Try to find all the different obstacles (24 in total) by clicking on the appearing green halos. A pop up will appear and explain the different hurdles on the road to translational medicine. You will see your progress in the upper right corner.

Building a Training network in translational research 

EATRIS offers diverse trainings open to any translational scientist but also clinicians, patient experts, regulators… to develop not only domain expertise, but also transversal skills important for advancing translational medicine.

EATRIS would like to create a network of training managers, trainers, managers of educational programmes and more generally all training enthusiasts.  This network will be an opportunity to exchange on the training needs and offers of our organisation as well as supporting each other, sharing best practices, etc.

We are very interested to hear about the training offers of your organisation, your needs and invite you to our network – so please fill in our short 6 minute survey

Are you planning to submit a grant proposal?
EATRIS can help strengthen your application

Horizon Europe is the EU’s key funding programme for research and innovation. As part of Horizon Europe, the Marie Skłodowska-Curie Actions Work Programme (MSCA) provides funding for training and equipping researchers with new knowledge and skills. In order to successfully secure MSCA funding, proposals need to demonstrate the ability to effectively train creative, entrepreneurial and innovative doctoral candidates, and be able to convert knowledge and ideas into products and services for economic and social benefit. Proposals also need to be cutting-edge, and include a plan for exploiting and disseminating results.